Long-term prescriptions in China for stable chronic conditions

Name the patient, medicine and refill task

Start with the person who will be assessed and the medicine that is actually being used. Match the passport or other accepted identity to the provider record, and bring the diagnosis and treatment history, recent clinical information, current prescription and the most recent dispensed package. A translated summary can help communication, but it does not replace the source record or create a Chinese prescription.

Define the immediate task: first long-term prescription, repeat issue, replacement after loss or expiry, supply after admission, online follow-up, pharmacy collection, shortage, or continuity after a move. These states require different checks. The Ningxia hospital-pharmacy guidance is one provider example of asking new patients to disclose medication and allergy history and repeat patients to bring the previous package; another provider may use a different workflow.

• Patient identity used by the provider
• Diagnosis and prior treatment record
• Exact medicine name, ingredient, strength and form
• Current prescription and dispensed package
• First, repeat, restart, shortage or transfer task

Check scope before expecting a long-term prescription

The national trial standards describe patients with a clear chronic diagnosis, a stable treatment plan, good adherence, stable control and an ongoing treatment need. That description is the starting framework, not automatic eligibility. The medical institution must have the relevant clinical and pharmacy capability, while local authorities can define the applicable condition and medicine scope.

The standards exclude specified toxic, radioactive, precursor, narcotic and psychotropic drugs, most antimicrobials, and medicines with special storage requirements. A clinician or pharmacist must classify the actual product under the current local rules. Do not infer eligibility from the disease name, a foreign prescription, a previous supply, an online listing or another patient's experience.

Ask the intended provider whether the condition, medicine and patient state are within its current long-term-prescription route before booking or travelling.

Build the first long-term-prescription record

For the first long-term prescription, the standards require a comprehensive assessment of the diagnosis, treatment, medication use, adherence, adverse reactions and other relevant conditions. Let the clinician decide whether the patient is suitable, record the plan and identify when follow-up or reassessment is required. Keep the issued prescription and encounter record; a spoken expectation or old package is not the prescription.

The national framework states that a long-term prescription supply is generally within four weeks and may, after appropriate assessment for a stable patient, be extended up to a twelve-week ceiling. These are administrative duration boundaries, not a promised amount. The clinician determines the prescription for the individual, and the pharmacy still reviews the issued prescription and actual product.

• First-assessment record
• Issued prescription and institution
• Medicine and product details as written
• Follow-up and reassessment point
• Patient education or confirmation required by the provider

This page explains administrative duration limits only; it never recommends a medicine, quantity or dose.

Treat every repeat issue as a new decision

A repeat issue is not an automatic copy. The clinician can use the first-assessment information and health record, but must assess the current condition, treatment, adherence and other changes before issuing the next prescription. Ask which record, test result, identity step or appointment the provider requires, and whether the next encounter can be online or must be in person.

The standards identify triggers for reassessment and possible termination, including failure to meet treatment targets, a new disease or medicine, hospitalization and other reasons the clinician considers relevant. If a long-term-prescription route was terminated and later restarted, the standards treat the restart as a first prescription. Preserve the admission, discharge, new-medicine and cancellation records rather than trying to refill around them.

• Current symptom and treatment record for the clinician
• New diagnosis, medicine or adverse-event information
• Hospital admission or discharge documents
• Provider decision: issue, reassess, change route or terminate
• Next review date and responsible service

Confirm dispensing before paying or travelling

After a valid long-term prescription is issued, the national standards allow the patient to choose dispensing at a medical institution or a social retail pharmacy. That policy choice does not mean every pharmacy can see, accept or stock every prescription. Confirm the actual prescription-transfer route, pharmacy location, pharmacist-review process, patient or representative identity, stock, payment and collection window before travelling.

At collection, compare the dispensed product with the prescription and provider instructions before leaving the counter. Check the patient name, medicine, ingredient, strength, dosage form, package count and any visible damage or storage issue, and ask the pharmacist to resolve a mismatch. The Ningxia hospital notice is a provider-specific example of checking the actual product at the window; it does not create a national no-return rule or authorize self-substitution.

• Hospital pharmacy or named retail-pharmacy route
• Prescription visibility and validity
• Stock and exact dispensed product
• Patient or representative identity
• Pharmacist review, payment and receipt
• Collection or provider-approved delivery status

Verify online follow-up and delivery separately

An internet-hospital route begins with the responsible medical institution and an eligible follow-up encounter. The national standards make internet-hospital long-term prescriptions subject to the conditions of the supporting physical institution. PUMCH and Renji publish examples involving existing-patient or patient-card identity, clinician review, electronic records or orders, payment, prescription services and displayed delivery options; they are examples of those providers, not a nationwide promise.

If a prescription passes to an online retailer, the national online-sales rules separately require prescription-source verification, pharmacist review and dispensing, marking the electronic prescription as used to prevent reuse, and appropriate storage, delivery and traceability. Confirm whether the provider's current official channel supports the patient, specialty, medicine, address and payment route. Do not reuse the same prescription across platforms or treat a delivery button as proof of clinical eligibility or stock.

• Official hospital or internet-hospital channel
• Identity and established-patient requirements
• Clinician acceptance and encounter status
• Electronic record, prescription and payment status
• Pharmacist review and prescription-use status
• Deliverable address, storage and handover route

Close shortages, moves and record handoffs

If the medicine cannot be dispensed as written, stop at the administrative problem: ask the pharmacy to record whether the issue is stock, prescription visibility, validity, product mismatch, review, payment or delivery. Return the record to the issuing provider or its pharmacist service. Do not change the ingredient, strength, dosage form, brand, quantity or schedule through this page or an informal message.

Before moving city or changing provider, export or securely save the visit record, prescription, dispensed-product details, invoices, pharmacy messages, test results and the next reassessment plan. Ask the receiving provider what it accepts and expect a new assessment where required; a portal screenshot or foreign prescription may support history but does not transfer prescribing authority. If the patient is hospitalized, develops a new condition or starts another medicine, route the change back for clinical reassessment before seeking the next issue.

• Written shortage or dispensing outcome
• Issued prescription and encounter record
• Dispensed-product and receipt history
• Hospitalization, new-condition or new-medicine record
• Exported portal and test records
• Receiving provider and next assessment plan